1,6500
22-ноября-24 15:44:58
15 мин. задержка
Акции
+0,0500
+3,12%
Сегодняшний диапазон
1,5800 - 1,6800
ISIN
N/A
Источник
NASDAQ
Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024
02 апр 2024 06:00:00 Источник Nasdaq GlobeNewswire
Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis
25 мар 2024 06:06:46 Источник Nasdaq GlobeNewswire